Novel technique may improve detection of aggressive prostate cancer

A molecular imaging biomarker detects fast-growing prostate cancer (PCa) on positron-emission tomography-computed tomography (PET-CT) and differentiates it from benign lesions, a small study finds.

The study employed the radiotracer 18F-DCFBC targeting the prostate-specific membrane antigen (PSMA), which is associated with PCa aggressiveness. If PSMA-based radiotracers continue to prove reliable, combining PET-CT results with magnetic resonance imaging (MRI) can improve PCa detection. Read more.

Tags: Cancer PET Prostate Research

About NMC  |  Products  |  Quote  |  News  |  Resources  |  Contact  |  Sitemap